Relation between high-sensitivity C-reactive protein levels and prognosis in patients treated with primary percutaneous coronary intervention after acute myocardial infarction
Shifang Ding
Abstract
Shifang Ding
Abstract
AIM: To study the relationship between high-sensitivity C-reactive protein(hs-CRP) levels and prognosis in patients treated with primary percutaneous coronary intervention(PCI) after acute myocardial infarction(AMI).METHODS: Two hundred and fifteen patients treated with primary PCI after AMI from January 2007 to January 2011 were reviewed and their plasma hs-CRP levels were studied.Plasma hs-CRP concentrations were compared between patients who had a cardiovascular(CV) event and those without.Patients were divided into different groups according to their plasma hs-CRP concentration,and the CV event incidences were compared between groups.RESULTS: A significant difference was found in hs-CRP levels between patients with a CV event and patients without(10±4) mg/L vs.(6±5) mg/L,P0.05).CV event incidences in various hs-CRP level groups were,respectively,hs-CRP 0-3 mg/L 23%,hs-CRP 3-6 mg/L 24%,hs-CRP 6-9 mg/L 47%,hs-CRP 9-12 mg/L 52%,and hs-CRP 12-15 mg/L 70%.Logistic regression analysis showed that the hs-CRP level was significantly related to the incidence of CV event,after correction for gender and age.CONCLUSION: hs-CRP is a prognostic factor in patients treated with primary PCI after AMI,the higher the hs-CRP,the higher the rate of CV event.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To study the relationship between high-sensitivity C-reactive protein(hs-CRP) levels and prognosis in patients treated with primary percutaneous coronary intervention(PCI) after acute myocardial infarction(AMI).METHODS: Two hundred and fifteen patients treated with primary PCI after AMI from January 2007 to January 2011 were reviewed and their plasma hs-CRP levels were studied.Plasma hs-CRP concentrations were compared between patients who had a cardiovascular(CV) event and those without.Patients were divided into different groups according to their plasma hs-CRP concentration,and the CV event incidences were compared between groups.RESULTS: A significant difference was found in hs-CRP levels between patients with a CV event and patients without(10±4) mg/L vs.(6±5) mg/L,P0.05).CV event incidences in various hs-CRP level groups were,respectively,hs-CRP 0-3 mg/L 23%,hs-CRP 3-6 mg/L 24%,hs-CRP 6-9 mg/L 47%,hs-CRP 9-12 mg/L 52%,and hs-CRP 12-15 mg/L 70%.Logistic regression analysis showed that the hs-CRP level was significantly related to the incidence of CV event,after correction for gender and age.CONCLUSION: hs-CRP is a prognostic factor in patients treated with primary PCI after AMI,the higher the hs-CRP,the higher the rate of CV event.
Key concepts: Medicine, Percutaneous coronary intervention, Myocardial infarction, C-reactive protein, Internal medicine, Conventional PCI, Incidence (geometry), Cardiology